• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEUROPACE, INC. NEUROPACE RNS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEUROPACE, INC. NEUROPACE RNS SYSTEM Back to Search Results
Model Number RNS 320
Medical Device Problem Code Premature Discharge of Battery (1057)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/04/2022
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4) the explanted device was discarded by the treating center and not returned to neuropace for investigation.Review of the battery performance - the battery performance of rns-320, sn (b)(4) was investigated.The pdms battery voltage plot shows a rapid and unusual voltage decrease starting around (b)(6) 2021.There is no interrogation data between 10/7/2021 and 2/2/2022.Available data show that stimulation parameters, detection rates and electrode impedances are in the normal range.Battery performance monitoring tools were used to assess this device.They show that, while the charge consumption for the device remained in a normal at around 0.19 to 0.20 milliamp hours per day, the battery voltage was comparatively low starting around (b)(6) 2020, after being implanted for 1.2 years.Starting in (b)(6) 2020, the battery voltage was in the bottom 5th percentile for rns-320 devices with similar cumulative charge expenditure for 9 of 11 months before it reached eos.This data supports an interpretation of premature eos for the device.Neuropace was unable to determine the cause of the early battery depletion based on device data analysis.
 
Event or Problem Description
The neurostimulator was replaced on (b)(6) 2022 for an unexpected end of life.The battery plot voltage was observed to deplete prematurely.Investigation of the neurostimulator data support an interpretation of premature early end of service for the device.After explant the treating center discarded the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROPACE RNS SYSTEM
Common Device Name
NEUROPACE RNS SYSTEM
Manufacturer (Section D)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer (Section G)
NEUROPACE, INC.
455 n. bernardo ave.
mountain view CA 94043
Manufacturer Contact
ramona gonis
455 n. bernardo ave.
mountain view, CA 94043
6502382788
MDR Report Key14283327
Report Number3004426659-2022-00007
Device Sequence Number4874702
Product Code PFN
UDI-Device Identifier00855547005267
UDI-Public010085554700526717200605
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P100026
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 05/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model NumberRNS 320
Device Catalogue Number1007694
Device Lot Number28458-1-1-1
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 04/04/2022
Initial Report FDA Received Date05/04/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age66 YR
Patient SexFemale
-
-